Comments
Apollo Hospitals has tied up with the US-based AliveCor Inc. to provide mobile electrocardiogram (ECG) devices to patients suffering from arrhythmias.
The heart-monitor device, approved by the US Food and Drug Administration (USFDA), would be sold to patients for ₹12,000 to keep a tab on their heartbeat, Dr Pratap C Reddy, Chairman, Apollo Hospitals, told newspersons here on Tuesday.
The device is smart phone-enabled and compatible with global standards.
“It can wirelessly record, display, store and transfer hear rate and single channel electrocardiogram to a doctor remotely located,’’ said Euan Thomson, President and Chief Executive Officer, AliveCor.
According to Sangeetha Reddy, Joint Managing Director, Apollo Hospitals, the monitor can be connected to a central round-the-clock station for interpretation of data/reading of the report for a monthly subscription of ₹1,000 for the first three months.
The charges for subsequent period were being worked out, she said.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.